Grass-roots Party Organizations Learn Twenty Spirits
Release time:
2022-11-23
Peak Health Party Branch
News In order to comprehensively and thoroughly study and implement the Party's 20 major spirits and encourage Party members and cadres to work hard and courageously, on the afternoon of July 11# and 16 , the Party Branch of Peak Health Technology Company held a special party class to learn and publicize the Party's 20 major spirits.
It is of great practical and far-reaching historical significance to study, publicize and implement the spirit of the 20th National Congress of the Communist Party of China. In this party class, Chen Daiyou, secretary of the Jianfeng Health Party Branch, focused on the birth of the report, the important spirit of the report, and the significance of studying, publicizing and implementing the spirit of the 20th National Congress of the Party.
All Party members of the Peak Health Party Branch, the management team of Peak Health and Cable Company, and cadres and workers of workshop departments participated in the study. After the study, the participants expressed that they must unify their thoughts and actions into the spirit of the 20th National Congress of the Communist Party of China, listen to the party, feel the party's favor, follow the party, love their jobs and work hard, and promote the high quality of enterprises with a strong sense of mission. Develop and contribute to the prosperity of the motherland.
(Zhou Guangliang)Blonde Group Party Committee
News 11 14 Afternoon, Blonde Group Party Committee held an enlarged meeting to study and implement the Party's 20 major spirits, convey the study and implementation of the Party's 20 major spirits, and deploy Blonde Group to implement the work.
Chen Jianzhong, Secretary of the Party Committee of Jinfa Group, pointed out that the 20th National Congress of the Party is a very important meeting held at a critical moment when my country is embarking on a new journey of building a modern socialist country in an all-round way and the process of striving for the second centenary goal. Comprehensively conveying, studying and implementing the spirit of the 20th National Congress of the Communist Party of China is the primary political task at present and in the future. He demanded that party organizations at all levels of the golden hair group should earnestly strengthen organizational leadership, meticulously carry out study, carry out in-depth publicity and propaganda, strengthen guidance and supervision, and rapidly rise an upsurge to convey, study and implement the spirit of the 20th CPC National Congress. The broad masses of party members, cadres and workers should bear in mind that General Secretary Xi Jinping pointed out that they should take the lead in abiding by the party constitution, party rules, party discipline and state laws and regulations, laws and regulations, laws and regulations, and regulations, and regulations, and regulations, establish a good image; take the lead in studying and propagating the spirit of the 20th National Congress of the Communist Party of China, actively guide the party members and the masses to unify their thoughts and actions into the spirit of the 20th National Congress, unify to implement the major decisions and deployments of the Party Central Committee, and do a solid and effective job in various tasks. Give full play to the exemplary and leading role of grassroots party members.
Members of the Party Committee of Jinfa Group, Party branch secretaries of various departments and some key Party members attended the meeting.
(Zhao Hong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31